Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice

Critical Care Medicine

Volumn 34, Issue 3, 2006, Pages 842-849

  Cook, Charles H ^a   Zhang, Yingxue ^a   Sedmak, Daniel D ^a   Martin, Larry C ^a   Jewell, Scott ^a   Ferguson, Ronald M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GANCICLOVIR; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; CYTOMEGALOVIRUS; FEMALE; GRAFT RECIPIENT; HERPES VIRUS; IMAGE ANALYSIS; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LUNG FIBROSIS; LUNG HOMOGENATE; LUNG PARENCHYMA; MOUSE; NEUTROPHIL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; STAINING; VIRUS INFECTION; VIRUS REACTIVATION;

ANIMALS; ANTIVIRAL AGENTS; CHEMOKINES; CYTOKINES; CYTOMEGALOVIRUS; FEMALE; GANCICLOVIR; IMMUNOCOMPETENCE; LUNG; MICE; MICE, INBRED BALB C; PULMONARY FIBROSIS; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VIRUS ACTIVATION;

EID: 33644597887     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000201876.11059.05     Document Type: Article

References (54)

1. Simmons RL, Matas AJ, Rattazzi LC, et al: Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 1977; 82:537-546
2. Cook CH, Yenchar JK, Kraner TO, et al: Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg 1998; 176:357-360
3. Cook CH, Martin LC, Tenchar JK, et al: Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 2003; 31:1923-1929
4. Heininger A, Jahn G, Engel C, et al: Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001; 29:541-547
5. Curtsinger LJ, Cheadle WG, Hershman MJ, et al: Association of cytomegalovirus infection with increased morbidity is independent of transfusion. Am J Surg 1989; 158: 606-611
6. Papazian L, Fraisse A, Garbe L, et al: Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996; 84:280-287
7. Mera JR, Whimbey E, Elting L, et al: Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: Review of 20 cases occurring from 1964 through 1990. Clin Infect Dis 1996; 22:1046-1050
8. Heininger A, Vogel U, Aepinus C, et al: Disseminated fatal human cytomegalovirus disease after severe trauma. Crit Care Med 2000; 28:563-566
9. Toorkey CB, Carrigan DR: Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues. J Infect Dis 1989; 160:741-751
10. Cushing D, et al: Herpes simplex virus and cytomegalovirus excretion associated with increased ventilator days in trauma patients. Abstr. J Trauma 1993; 25:161
11. Bevan IS, Sammons CC, Sweet C: Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction. J Med Virol 1996; 48:308-320
12. Furrarah AM, Sweet C: Studies of the pathogenesis of wild-type virus and six temperature-sensitive mutants of mouse cytomegalovirus. J Med Virol 1994; 43:317-330
13. Cook C, Zhang Y, McGuinness BJ, et al: Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J Infect Dis 2002; 185: 1395-1400
14. Henson D, Smith RD, Gehrke J: Non-fatal mouse cytomegalovirus hepatitis. Combined morphologic, virologic and immunologic observations. Am J Pathol 1966; 49:871-888
15. Collins T, Pomeroy C, Jordan MC: Detection of latent cytomegalovirus DNA in diverse organs of mice. J Infect Dis 1993; 168:725-729
16. Balthesen M, Messerle M, Reddehase MJ: Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993; 67:5360-5366
17. Kurz S, Steffens HP, Mayer A, et al: Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 1997; 71:2980-2987
18. Kurz SK, Rapp M, Steffens HP, et al: Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol 1999; 73:482-494
19. Holtappels R, Podlech J, Geginat G, et al: Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J Virol 1998; 72:7201-7212
20. National Research Council: Guide for the Care and Use of Laboratory Animals (NIH Publication 86-23). Bethesda, MD, National Institutes of Health, 1985
21. Simon CO, Seckert CK, Dreis D, et al: Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 2005; 79: 326-340
22. Reddehase MJ, Podlech J, Grzimek NK: Mouse models of cytomegalovirus latency: Overview. J Clin Virol 2002; 25(Suppl 2): S23-S36
23. Baker CC, Chaudry IH, Gaines HO, et al: Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94:331-335
24. Duan J, Paris W, Kibler P, et al: Dose and duration-dependence of ganciclovir treatment against murine cytomegalovirus infection in severe combined immunodeficient mice. Antiviral Res 1998; 39:189-197
25. Rubin RH, Lynch P, Pasternack MS, et al: Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice. Antimicrob Agents Chemother 1989; 33:1975-1979
26. Salkowski CA, Detore G, Franks A, et al: Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect Immun 1998; 66:3569-3578
27. Huang S, Paulauskis JD, Godleski JJ, et al: Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol 1992; 141:981-988
28. Tsujimoto H, Ono S, Mochizuki H, et al: Role of macrophage inflammatory protein 2 in acute lung injury in murine peritonitis. J Surg Res 2002; 103:61-67
29. Mercer-Jones MA, Heinzelmann M, Peyton JC, et al: The pulmonary inflammatory response to experimental fecal peritonitis: Relative roles of tumor necrosis factor-alpha and endotoxin. Inflammation 1997; 21:401-417
30. Sime PJ, Marr RA, Gauldie D, et al: Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-β1 and myofibroblasts. Am J Pathol 1998; 153: 825-832
31. Warshamana GS, Corti M, Brody AR: TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: TNF-alpha induces TGF-beta(1). Exp Mol Pathol 2001; 71:13-33
32. Ayala A, Song GY, Chung CS, et al: Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin. Crit Care Med 2000; 28:2949-2955
33. Ayala A, Chaudry IH: Immune dysfunction in murine polymicrobial sepsis: Mediators, macrophages, lymphocytes and apoptosis. Shock 1996; 6(Suppl 1):S27-S38
34. Ebong SJ, Call DR, Bolgos G, et al: Immunopathologic responses to non-lethal sepsis. Shock 1999; 12:118-126
35. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001; 163:316-321
36. Podlech J, Holtappels R, Pahl-Siebert MF, et al: Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: Persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 2000; 74: 7496-7507
37. Reddehase MJ, Balthesen M, Rapp M, et al: The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 1994; 179:185-193
38. Murayama T, Mukaida N, Sadanari H, et al: The immediate early gene 1 product of human cytomegalovirus is sufficient for upregulation of interleukin-8 gene expression. Biochem Biophys Res Commun 2000; 279: 298-304
39. Geist LJ, Hopkins HA, Dai LY, et al: Cytomegalovirus modulates transcription factors necessary for the activation of the tumor necrosis factor-alpha promoter. Am J Respir Cell Mol Biol 1997; 16:31-37
40. Gribaudo G, Ravaglio S, Guandalini L, et al: The murine cytomegalovirus immediate-early 1 protein stimulates NF-kappa B activity by transactivating the NF-kappa B p 105/ p50 promoter. Virus Res 1996; 45:15-27
41. Yurochko AD, Hwang ES, Rasmussen L, et al: The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol 1997; 71:5051-5059
42. Yurochko AD, Kowalik TF, Huong SM, et al: Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 1995; 69:5391-5400
43. Yurochko AD, Mayo MW, Poma EE, et al: Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/ p50 NF-kappaB promoters. J Virol 1997; 71: 4638-4648
44. Kowalik TF, Wing B, Haskill JS, et al: Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A 1993; 90:1107-1111
45. Yerkovich ST, Olver SD, Lenzo JC, et al: The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection. Immunology 1997; 91:45-52
46. Koffron A, Varghese T, Hummel M, et al: Immunosuppression is not required for reactivation of latent murine cytomegalovirus. Transplant Proc 1999; 31:1395-1396
47. Docke WD, Prosch S, Fietze E, et al: Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994; 343:268-269
48. Thrall RS, Vogel SN, Evans R, et al: Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. Am J Pathol 1997; 151:1303-1310
49. Liu J-Y, Brass DM, Hoyle GW, et al: TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 1998; 153: 1839-1847
50. Piguet PF, Ribaux C, Karpuz V, et al: Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 1993; 143: 651-655
51. Huaux F, Arras M, Vink A, et al: Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice. Am J Respir Cell Mol Biol 1999; 21:137-145
52. Liu JY, Sime PJ, Wu T, et al: Transforming growth factor-beta(1) overexpression in tumor necrosis factor-alpha receptor knockout mice induces fibroproliferative lung disease. Am J Respir Cell Mol Biol 2001; 25:3-7
53. Sime PJ, Xing Z, Graham FL, et al: Adenovector-mediated gene transfer of active transforming growth factor-beta 1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100:768-776
54. Bruynseels P, Jorens PG, Demey HE, et al: Herpes simplex virus in the respiratory tract of critical care patients: A prospective study. Lancet 2003; 362:1536-1541